EP
CHE icon

Eudaimonia Partners’s Chemed CHE Stock Holding History

Eudaimonia Partners’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-221
Closed -$102K – 530
2021
Q1 		$102K Buy
221
+4
+2% +$1.96K 0.02% 475
2020
Q4 		$116K Sell
217
-1
-0.5% -$491 0.03% 413
2020
Q3 		$105K Buy
218
+111
+104% +$54.4K 0.03% 397
2020
Q2 		$48K Buy
+107
New +$47.8K 0.02% 511

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Eudaimonia Partners's CHE Position: Q2 2021 in Review

Eudaimonia Partners sold out of Chemed (CHE) in Q2 2021, closing a stake of 221 shares — an estimated $102K sold.

Eudaimonia Partners first reported a position in CHE in Q2 2020 and held it in 4 quarters. The position peaked at $116K in Q4 2020. 425 funds tracked by Wall St. Rank hold CHE as of Q2 2021.

  • Eudaimonia Partners reported no remaining Chemed position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 221 Chemed shares in Q2 2021, an estimated $102K.
  • Eudaimonia Partners first reported a position in Chemed in Q2 2020 and held it in 4 quarters.
  • Eudaimonia Partners's Chemed position peaked at $116K in Q4 2020.
  • 425 funds tracked by Wall St. Rank held Chemed as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.